JAMA Clinical Reviews podcast

Review of Cardiac Resynchronization Therapy

0:00
19:57
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS.

Related Content:

Altri episodi di "JAMA Clinical Reviews"